EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways

Amira Mohammed Abdelfattah iD, Zeinab A Mohammed, Aliaa Talaat, Walaa Samy, Mamdouh Eldesoqui, Reham I Elgarhi iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03393-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Amira Mohammed Abdelfattah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Renal Insufficiency, Chronic, Vinca Alkaloids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zagazig University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tubulointerstitial fibrosis (TIF) is present with chronic kidney disease (CKD). Vinpocetine (Vinpo) is used for treating cerebrovascular deficits, exhibiting some kidney-beneficial effects; however, its role in TIF is uncertain. So, the aim of this study was to investigate its potential impact on adenine-induced fibrotic CKD and explore the underlying mechanistic aspects. Eighteen male Wistar rats were categorized into three groups ( n = 6 each). Group I was kept as controls and given saline; group II received adenine (300 mg/kg, twice weekly, i.p.) for induction of the CKD model; and group III was administered Vinpo (20 mg/kg/d, orally) concurrently with adenine. All treatments were administered for 4 weeks. Vinpo revealed an improvement in renal function and an alleviation of inflammation triggered by adenine via diminishing serum tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) levels. Further, Vinpo repressed the epithelial-mesenchymal transition (EMT) with preserved E-cadherin mRNA expression and lowered gene and immune expression of fibronectin and vimentin, respectively, besides attenuating the elevated G2/M arrest-related molecules (renal Ki67 protein contents and p21 gene expression). Renal pathological alterations caused by adenine were attenuated upon Vinpo administration. Interestingly, Vinpo suppressed abnormal renal β-catenin immunoreactivity, Snail 1, and MMP-7 gene expression while simultaneously restored Klotho protein expression by downregulating DNA methyltransferase 1 enzyme (DNMT1) protein expression in the kidney. These data indicated that Vinpo effectively mitigated EMT and G2/M arrest-induced renal fibrosis in adenine-induced CKD rats by targeting DNMT1-associated Klotho suppression, subsequently inhibiting β-catenin and its fibrotic downstream genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionRenal Insufficiency, ChronicVinca AlkaloidsAnimalsMaleRats, WistarDNA (Cytosine-5-)-Methyltransferase 1AdenineFibrosisbeta CateninSnail Family Transcription FactorsKlotho ProteinsGlucuronidaseMatrix Metalloproteinase 7RatsKidneySignal Transduction

Stichwörter der Autor:innen

AdenineChronic kidney disease (CKD)Epithelial-mesenchymal transitionKlothoVinpocetineβ-Catenin

Substanzen

DNA (Cytosine-5-)-Methyltransferase 1Adeninevinpocetinebeta CateninSnail Family Transcription FactorsVinca AlkaloidsKlotho ProteinsGlucuronidaseDnmt1 protein, ratMatrix Metalloproteinase 7

Autor:innen und Institutionen

  • Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, 11597, Riyadh, Saudi Arabia.
  • Department of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
  • Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. reham.elgarhi@yahoo.com.

ORCID-Profile: Amira Mohammed Abdelfattah, Reham I Elgarhi

Förderung

  • Zagazig University

Zitieren

APA

Abdelfattah, A. M., Mohammed, Z. A., Talaat, A., Samy, W., Eldesoqui, M., & Elgarhi, R. I. (2025). A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03393-0

Vancouver

Abdelfattah AM, Mohammed ZA, Talaat A, Samy W, Eldesoqui M, Elgarhi RI. A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03393-0

BibTeX
@article{Abdelfattah2025,
  author = {Abdelfattah, Amira Mohammed and Mohammed, Zeinab A and Talaat, Aliaa and Samy, Walaa and Eldesoqui, Mamdouh and Elgarhi, Reham I},
  title = {A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03393-0}
}
Kostenlos starten →